查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049460

感染控制市場報告：按類型、最終用戶和地區分類（2026-2034 年）

Infection Control Market Report by Type (Equipment, Services, Consumables), End User (Hospitals and Clinics, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2025年全球感染控制市場規模達299億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以5.97%的複合年成長率成長，到2034年達到511億美元。北美憑藉其完善的醫療保健基礎設施和廣泛應用的消毒滅菌技術，在市場中佔據主導地位。此外，診斷和感染控制設備的快速技術進步、獸醫和動物護理領域需求的成長、感染疾病預防研發投入的活性化以及對預防醫療相關感染（HAI）日益成長的關注，都在推動市場成長。

公眾和醫療專業人員的衛生和安全意識顯著提高。醫療機構優先考慮消毒和衛生管理，以防止交叉感染。這種意識正在向患者傳播，促使醫療機構投入更多資源用於感染控制。對更安全環境的需求不斷推動著產業對更先進產品和流程的需求。此外，消毒劑和耗材的持續進步提高了其有效性和易用性。自動化消毒系統、改良化學品和即時監測工具現已廣泛應用。這些創新技術對現代醫療運作而言極具吸引力，因為它們在改善治療效果的同時，也能降低人事費用和長期費用。此外，計劃手術和急診手術數量的增加也推動了對無菌環境的需求。手術室需要嚴格的感染控制，涉及各種耗材和器械。手術數量的增加提高了對統一感染控制的需求，這已成為醫療機構的優先領域。

感染控制市場的發展趨勢：

老年人口增加

全球老年人口的顯著成長正在對感染控制市場產生至關重要的影響。世界衛生組織（世衛組織）預測，到2030年，全球六分之一的人口將超過60歲，全球老年人口預計將從2020年的10億增至2030年的約14億，到2050年預計將達到約21億。由於老年人的免疫反應普遍較弱，且更容易受到感染疾病，這些人口結構變化對醫療保健系統產生了直接影響。因此，醫院、養老院和長期照護機構對嚴格感染控制措施的需求正在穩步成長。保持嚴格的衛生標準並實施最先進的消毒技術對於管理這一年齡層的患者至關重要。這些因素進一步對感染控制市場的預測產生了正面影響。

醫療相關感染（HAI）增加

全球醫院和臨床機構中醫療相關感染疾病（HAI）的發生率不斷上升，已成為一個嚴峻的問題，顯著增加了對有效感染控制策略的需求。常見的HAI，例如手術部位感染、導管相關感染和人工呼吸器相關性肺炎，對患者的健康構成重大威脅，導致住院時間延長、醫療成本增加和發病率升高。根據歐洲疾病預防控制中心（ECDC）的報告，歐盟/歐洲經濟區（EU/EEA）每年約有430萬住院患者感染至少一種HAI。這項令人震驚的統計數據凸顯了加強感染預防措施以及採用最先進的消毒和滅菌技術的迫切需求。醫療機構正逐步增加對感染控制產品的投入，以確保病患安全並符合嚴格的監管要求。降低感染率的日益關注正在推動感染控制行業的成長。

擴大門診醫療服務

門診醫療模式的興起是推動感染控制產品和技術需求成長的主要因素。這些無需住院即可提供醫療服務的門診中心，因其便利、經濟和易得性而日益普及。根據 Publisher Group 的一份報告顯示，全球門診服務市場規模將在 2023 年達到 3.8 兆美元，預計 2024 年至 2032 年將以 5.7% 的複合年成長率成長，到 2032 年將達到 6.3 兆美元。隨著門診患者數量的增加，對嚴格感染控制措施的需求也隨之增加。由於患者周轉率高、治療週期短以及需要防止交叉感染，這些機構需要可靠的消毒、表面消毒和個人防護裝備。門診機構對安全性和合規性的日益重視預計將推動感染控制市場的收入成長。

感染控制市場成長要素：

技術進步與產品創新

消毒和滅菌技術的進步正在改變感染控制市場，提高其準確性、效率和對不斷變化的臨床需求的適應性。材料、自動化系統、化學品和監測平台的改進正在增強感染控制的可靠性和安全性。一個值得關注的例子是Getinge公司於2024年推出的Poladus 150。這款低溫過氧化氫（VH2O2）滅菌器專為熱敏性手術器械而設計。它採用先進的交叉污染預防技術​​，旨在最佳化滅菌供應單元流程，同時最大限度地減少醫療相關感染。該系統還與數位平台整合，從而提高了醫院內再處理流程的可追溯性和操作效率。這些創新使醫護人員能夠更一致地執行滅菌程序並減少錯誤。注重自動化、可追溯系統和直覺的介面最大限度地減少了勞動密集型工作，並加強了合規性。隨著醫療機構越來越意識到這些技術帶來的成本和安全優勢，它們的應用正在加速普及。

公共衛生宣傳活動和政府努力

政府主導的公共衛生宣傳活動和政策舉措對於加強感染控制措施至關重要。這些措施旨在提高公眾衛生意識，鼓勵合理使用抗菌藥物，並在臨床環境和社區中推廣最佳實踐。政府機構經常撥出資源，加強公立醫院的感染控制系統，提供獎勵以促進合規，並支持追蹤感染模式的監測活動。國家衛生策略正逐步將感染預防作為首要目標，確保各機構與更廣泛的衛生目標一致。針對醫護人員和民眾的宣傳活動能夠促進行為改變，進而降低感染風險。這些宣傳活動也能增加對消毒劑、滅菌器和防護工具等標準化產品的需求。這些措施在提高公共安全的同時，也創造了持續的需求，尤其是在那些意識和基礎設施仍在發展中的地區。

產業合作

醫療設備製造商與醫療保健相關人員之間的合作對於推動感染控制市場的擴張至關重要。此類合作關係有助於提高公眾意識，加強教育，並推廣應對關鍵醫療保健挑戰（尤其是在感染預防方面）的最尖端科技。近期的例子是Bactiguard和BD在印度CRITICARE 2025大會上的合作。雙方都強調了解決醫療相關感染（HAI）和抗菌素抗藥性（AMR）的重要性，尤其是在重症監護環境中。大會期間舉辦的臨床研討會重點介紹了Bactiguard塗層導尿管在減少導尿管相關尿道感染（CAUTI）和促進合理使用抗生素方面的優勢。 BD也宣布，這些尖端設備即將進入印度市場。這些努力不僅將先進技術帶到了急需的地區，而且進一步強化了產業夥伴關係在推動全球感染控制目標、提高病患安全和擴大市場進入的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球感染控制市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 裝置
    • 主要類型
      • 消毒設備
        • 洗滌裝置
        • 內部清潔裝置
        • 超音波清洗設備
      • 消毒器
        • 熱力滅菌
        • 低溫滅菌
        • 放射線殺菌
        • 過濾滅菌
      • 其他
  • 服務
    • 主要類型
      • 合約滅菌
        • 環氧乙烷滅菌
        • 伽瑪射線滅菌
        • 電子束滅菌
        • 蒸氣滅菌
      • 傳染性廢棄物的處理
  • 消耗品
    • 主要類型
      • 消毒劑
      • 滅菌耗材
      • 個人防護設備
      • 其他

第7章 市場區隔：依最終用戶分類

  • 醫院和診所
  • 醫療設備製造商
  • 臨床實驗室
  • 製藥公司
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • 3M Company
    • Advanced Sterlization Products Services Inc.（Fortive Corporation）
    • Belimed AG（Metall Zug）
    • Cantel Medical Corp.
    • Getinge AB
    • Matachana
    • Metrex Research LLC（Envista Holdings and Sybron Dental Specialities Inc）
    • MMM Munchener Medizin Mechanik GmbH
    • Pal International
    • Sterigenics US LLC（Sotera Health Holdings LLC）
    • Steris Corporation
    • TSO3 Inc.（Stryker Corporation）
Product Code: SR112026A2509

The global infection control market size reached USD 29.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 51.1 Billion by 2034, exhibiting a growth rate (CAGR) of 5.97% during 2026-2034. North America dominates the market because of robust healthcare infrastructure and widespread adoption of sterilization and disinfection technologies. Moreover, the rapid technological advancements in diagnostic and infection control equipment, the increasing demand in veterinary and animal care settings, rising R&D in infectious disease prevention, and the growing focus on preventing healthcare-associated infections (HAIs) are some of the factors propelling the market growth.

Awareness about hygiene and safety among the public and institutions is rising considerably. Healthcare providers emphasize sterilization and hygiene to avoid cross-contamination. This consciousness spreads to patients, motivating institutions to allocate more resources to infection control. The drive for safer surroundings is consistently driving the need for enhanced products and protocols in the industry. Furthermore, ongoing advancements in disinfection tools and supplies are enhancing both their efficacy and user-friendliness. Automated sterilization systems, enhanced chemical formulations, and real-time monitoring tools are now easily available. These innovations improve results while lowering labor and long-term expenses, making them appealing investments for contemporary healthcare operations. Besides this, the increase in elective and emergency surgeries results in a greater need for sterile environments. Surgical suites necessitate rigorous infection control measures, involving a wide array of supplies and instruments. With the rise in surgical volumes, the necessity for uniform infection control grows, making it a key area of focus for healthcare institutions.

Infection Control Market Trends:

Increasing Geriatric Population

There has been a notable rise in the global geriatric population, which plays a crucial role in shaping the infection control market. As projected by the World Health Organization (WHO), by the year 2030, one in six people globally will be aged 60 and above, with the worldwide senior population anticipated to rise from 1 billion in 2020 to approximately 1.4 billion by 2030. By the year 2050, this figure is expected to be around 2.1 billion. This change in demographics directly affects healthcare systems, as older individuals commonly exhibit weaker immune responses and increased vulnerability to infections. As a result, the need for strict infection control measures in hospitals, nursing homes, and long-term care facilities is growing consistently. Upholding rigorous hygiene standards and implementing cutting-edge sterilization methods are crucial in managing this age demographic. These factors further positively influence the infection control market forecast.

Rising Prevalence of Healthcare-Associated Infections (HAI)

The growing frequency of healthcare-associated infections (HAIs) in hospitals and clinical environments in different areas is emerging as a significant issue, considerably driving the need for efficient infection control strategies. Frequent forms of HAIs, including surgical site infections, catheter-related infections, and ventilator-related pneumonia, represent significant health dangers to patients and lead to prolonged hospitalizations, rising healthcare costs, and elevated morbidity rates. A publication from the European Centre for Disease Prevention and Control indicates that nearly 4.3 million hospital patients in the EU/EEA acquire at least one HAI each year. This concerning statistic highlights the critical necessity for improved infection prevention measures and the implementation of cutting-edge disinfection and sterilization technologies. Healthcare providers are progressively allocating resources to infection control products to guarantee patient safety and adhere to rigorous regulatory requirements. The increasing focus on lowering infection rates is strengthening the growth of the infection control industry.

Expanding Ambulatory Services Industry

The increasing transition towards outpatient services is becoming a major factor in driving the demand for infection control products and technologies. These outpatient care centers, providing medical services without the need for overnight hospital admissions, are becoming more popular because of their convenience, affordability, and accessibility. As reported by the publisher Group, the worldwide ambulatory services market attained a valuation of US$ 3.8 Trillion in 2023 and is expected to expand to US$ 6.3 Trillion by 2032, with a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032. As a result of this expansion, the number of patients receiving care in outpatient settings is increasing, which heightens the need for strict infection control measures. Due to high patient turnover, swift treatment cycles, and the necessity to avert cross-contamination, these facilities demand dependable sterilization, surface disinfection, and personal protective measures. The rising emphasis on safety and regulatory adherence in outpatient settings is anticipated to boost the infection control market revenue.

Infection Control Market Growth Drivers:

Technological Advancement and Product Innovation

Advancements in technology for disinfection and sterilization are transformed the infection control market, enhancing its precision, efficiency, and compatibility with changing clinical needs. Advancements in materials, automated systems, chemical substances, and monitoring platforms are enhancing reliability and safety in infection control. A prominent instance is the 2024 introduction of Getinge's Poladus 150, a low-temperature VH2O2 sterilizer designed specifically for heat-sensitive surgical tools. It featured cutting-edge cross-contamination prevention technology designed to minimize healthcare-related infections while optimizing processes in sterile supply units. The system also connected with digital platforms, providing improved traceability and operational effectiveness during hospital reprocessing. Such innovations enable healthcare personnel to execute sterilization procedures with improved uniformity and reduced mistakes. The focus on automation, traceable systems, and intuitive interfaces is minimizing labor-heavy tasks and enhanced adherence to regulations. With increasing awareness among healthcare providers regarding the cost and safety advantages of these technologies, their adoption is accelerating.

Public Health Campaigns and Government Initiatives

Public health campaigns and policy initiatives led by the government are vital in enhancing infection control measures. These initiatives enhance awareness about hygiene, encourage responsible use of antimicrobials, and advocate for best practices in clinical and community environments. Governing bodies frequently assign resources to enhance infection control systems in public hospitals, provide incentives for adherence, and back surveillance initiatives that track infection patterns. National healthcare strategies are progressively prioritizing infection prevention as a key goal, making sure that institutions align with wider health objectives. Educational outreach aimed at both healthcare professionals and the general public reinforces behavior modifications that help lower transmission risks. These campaigns also increase the demand for standardized items, such as disinfectants, sterilization devices, and protective gear. These initiatives enhance public safety while generating ongoing demand, especially in developing areas where awareness and infrastructure are still growing.

Industry Collaboration

Collaborative efforts between manufacturers of medical devices and healthcare stakeholders are essential in promoting the expansion of the infection control market. These collaborations promote awareness, education, and availability of cutting-edge technologies that tackle critical healthcare issues, especially in preventing infections. A recent instance is the collaborative effort by Bactiguard and BD at CRITICARE 2025 in India, where both organizations highlighted the significance of addressing healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), especially in intensive care settings. Throughout the event, clinical sessions emphasized the advantages of Bactiguard-coated catheters in decreasing catheter-associated urinary tract infections (CAUTI) and promoting responsible antibiotic usage. BD has also revealed the imminent release of these cutting-edge devices in the Indian market. These initiatives not only introduce advanced technologies to areas with significant needs but also strengthen the importance of industry partnerships in promoting worldwide infection control objectives, improving patient safety, and broadening market access.

Global Infection Control Industry Segmentation:

The publisher provides an analysis of the key trends in each segment of the global infection control market report, along with forecasts at the global, regional, and country levels from 2026-2034. Our report has categorized the market based on type and end user.

Breakup by Type:

  • Equipment
  • Disinfectors
  • Washers
  • Flushers
  • Ultrasonic Cleaners
  • Sterilization Equipment
  • Heat Sterilization
  • Low Temperature Sterilization
  • Radiation Sterilization
  • Filtration-Based Sterilization
  • Others
  • Services
  • Contract Sterilization
  • ETO Sterilization
  • Gamma Sterilization
  • E-Beam Sterilization
  • Steam Sterilization
  • Infectious Waste Disposal
  • Consumables
  • Disinfectants
  • Sterilization Consumables
  • Personal Protective Equipment
  • Others

Consumables dominate the market

According to the infection control market outlook, the consumables segment, including disinfectants, sterilization consumables, personal protective equipment (PPE), and other related products, is the largest market segment in the industry. These consumables play a critical role in preventing and controlling the spread of infections across various sectors, such as healthcare, food processing, and public spaces. Disinfectants are vital in healthcare facilities, laboratories, and public spaces to eliminate harmful pathogens on surfaces and minimize the risk of infections. Sterilization consumables, like autoclave bags and indicator tapes, are indispensable in maintaining sterile medical instruments and equipment conditions.

Breakup by End User:

  • Hospitals and Clinics
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Others

Hospitals and clinics dominate the market

According to the infection control market overview, the hospitals and clinics segment emerged as the largest market share holder in the industry, reflecting the critical role of infection prevention measures in healthcare settings. Hospitals and clinics are high-risk environments where vulnerable patients, healthcare professionals, and visitors come into close contact, making them susceptible to infectious diseases. Infection control is of utmost importance in these settings to curb the spread of healthcare-associated infections (HAIs) and safeguard patient safety. Strict protocols, including hand hygiene, sterilization of medical equipment, and the use of personal protective equipment (PPE), are integral to maintaining a safe and sterile environment. Besides this, with a growing focus on patient care, hospital accreditation, and regulatory compliance, the demand for these solutions in hospitals and clinics remains robust. As healthcare facilities strive to enhance infection prevention measures and reduce the burden of HAIs, the hospitals and clinics segment is expected to continue leading the market.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection control market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Russia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

According to the infection control market statistics, North America, comprising the United States and Canada, dominate the market, which can be attributed to several key factors driving its growth. The region's significant aging population contributes to the rising demand for infection control measures. For instance, according to an article published by the Population Reference Bureau, the number of people in the United States aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050 (a 47% increase), with the 65-and-over age group accounting for 17% to 23% of the overall population. Moreover, the region's technologically advanced healthcare infrastructure fosters the adoption of innovative infection control solutions, including advanced disinfectants, sterilization technologies, and smart medical devices.

Competitive Landscape:

Top companies catalyze the market by introducing innovative solutions and technologies to combat infectious diseases. These companies invest heavily in research and development, creating cutting-edge disinfection and sterilization products that effectively prevent the spread of infections. Their commitment to maintaining stringent quality standards and adherence to regulatory guidelines instills trust among healthcare providers, bolstering their market presence. Moreover, these companies actively engage in educational programs and awareness campaigns, emphasizing the importance of infection prevention and control measures. Continued efforts to expand their global footprint through strategic collaborations and acquisitions further fuel market growth. They address environmental concerns and attract environmentally-conscious consumers by prioritizing sustainability and eco-friendly practices.

The infection control market research report has provided a comprehensive analysis of the competitive landscape in the infection control market. Detailed profiles of all major companies have also been provided.

  • 3M Company
  • Advanced Sterlization Products Services Inc. (Fortive Corporation)
  • Belimed AG (Metall Zug)
  • Cantel Medical Corp.
  • Getinge AB
  • Matachana
  • Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.)
  • MMM Munchener Medizin Mechanik GmbH
  • Pal International
  • Sterigenics U.S. LLC (Sotera Health Holdings LLC)
  • Steris Corporation
  • TSO3 Inc. (Stryker Corporation)

Key Questions Answered in This Report:

  • How has the global infection control market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global infection control market?
  • What is the impact of each driver, restraint, and opportunity on the global infection control market?
  • What are the key regional markets?
  • Which countries represent the most attractive infection control market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the global infection control market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the global infection control market?
  • What is the competitive structure of the global infection control market?
  • Who are the key players/companies in the global infection control market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infection Control Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Disinfectors
        • 6.1.2.1.1 Washers
        • 6.1.2.1.2 Flushers
        • 6.1.2.1.3 Ultrasonic Cleaners
      • 6.1.2.2 Sterilization Equipment
        • 6.1.2.2.1 Heat Sterilization
        • 6.1.2.2.2 Low Temperature Sterilization
        • 6.1.2.2.3 Radiation Sterilization
        • 6.1.2.2.4 Filtration-Based Sterilization
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Contract Sterilization
        • 6.2.2.1.1 ETO Sterilization
        • 6.2.2.1.2 Gamma Sterilization
        • 6.2.2.1.3 E-Beam Sterilization
        • 6.2.2.1.4 Steam Sterilization
      • 6.2.2.2 Infectious Waste Disposal
    • 6.2.3 Market Forecast
  • 6.3 Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Disinfectants
      • 6.3.2.2 Sterilization Consumables
      • 6.3.2.3 Personal Protective Equipment
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medical Device Companies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Clinical Laboratories
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pharmaceutical Companies
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Advanced Sterlization Products Services Inc. (Fortive Corporation)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Belimed AG (Metall Zug)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Cantel Medical Corp.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Getinge AB
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Matachana
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 MMM Munchener Medizin Mechanik GmbH
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Pal International
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Sterigenics U.S. LLC (Sotera Health Holdings LLC)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Steris Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 TSO3 Inc. (Stryker Corporation)
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Infection Control Market: Major Drivers and Challenges
  • Figure 2: Global: Infection Control Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Infection Control Market: Breakup by Type (in %), 2025
  • Figure 4: Global: Infection Control Market: Breakup by End User (in %), 2025
  • Figure 5: Global: Infection Control Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Infection Control Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 7: Global: Infection Control (Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Infection Control (Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Infection Control (Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Infection Control (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Infection Control (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Infection Control (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Infection Control (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Infection Control (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Infection Control (Medical Device Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Infection Control (Medical Device Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Infection Control (Clinical Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Infection Control (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Infection Control (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Infection Control (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Infection Control (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Infection Control (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: North America: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: North America: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: United States: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: United States: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Canada: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Canada: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Asia Pacific: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Asia Pacific: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: China: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: China: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Japan: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Japan: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: India: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: India: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: South Korea: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: South Korea: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Australia: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Australia: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Indonesia: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Indonesia: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Others: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Others: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Europe: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Europe: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Germany: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Germany: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: France: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: France: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: United Kingdom: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: United Kingdom: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Italy: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Italy: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Spain: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Spain: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Russia: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Russia: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Latin America: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Latin America: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Brazil: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Brazil: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Mexico: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Mexico: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Middle East and Africa: Infection Control Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Middle East and Africa: Infection Control Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Global: Infection Control Industry: SWOT Analysis
  • Figure 72: Global: Infection Control Industry: Value Chain Analysis
  • Figure 73: Global: Infection Control Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infection Control Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Infection Control Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Infection Control Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 4: Global: Infection Control Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Infection Control Market: Competitive Structure
  • Table 6: Global: Infection Control Market: Key Players